Cargando…
Human liver stem cells express UGT1A1 and improve phenotype of immunocompromised Crigler Najjar syndrome type I mice
Crigler Najjar Syndrome type I (CNSI) is a rare recessive disorder caused by mutations in the Ugt1a1 gene. There is no permanent cure except for liver transplantation, and current therapies present several shortcomings. Since stem cell-based therapy offers a promising alternative for the treatment o...
Autores principales: | Famulari, Elvira Smeralda, Navarro-Tableros, Victor, Herrera Sanchez, Maria Beatriz, Bortolussi, Giulia, Gai, Marta, Conti, Laura, Silengo, Lorenzo, Tolosano, Emanuela, Tetta, Ciro, Muro, Andrés Fernando, Camussi, Giovanni, Fagoonee, Sharmila, Altruda, Fiorella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6972964/ https://www.ncbi.nlm.nih.gov/pubmed/31965023 http://dx.doi.org/10.1038/s41598-020-57820-2 |
Ejemplares similares
-
Long Term Liver Engraftment of Functional Hepatocytes Obtained from Germline Cell-Derived Pluripotent Stem Cells
por: Fagoonee, Sharmila, et al.
Publicado: (2015) -
Preclinical Development of an AAV8-hUGT1A1 Vector for the Treatment of Crigler-Najjar Syndrome
por: Collaud, Fanny, et al.
Publicado: (2018) -
Crigler-Najjar syndrome type 2: Novel UGT1A1 mutation
por: Nair, Karippoth Mohandas, et al.
Publicado: (2012) -
A translationally optimized AAV-UGT1A1 vector drives safe and long-lasting
correction of Crigler-Najjar syndrome
por: Ronzitti, Giuseppe, et al.
Publicado: (2016) -
Management of Crigler-Najjar syndrome
por: Tcaciuc, Eugen, et al.
Publicado: (2021)